Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ardea Biosciences, Inc.    RDEA

 SummaryNewsCalendarCompanyFinancials 
Company
More about the company
Latest news on ARDEA BIOSCIENCES, INC.
2012 AstraZeneca hungry to refill medicine cabinet
2012DJAstraZeneca Completes Acquisition of Ardea Biosciences
2012 GSK goes hostile with $2.6 billion Human Genome offer
2012 Biotech targets fight back as Big Pharma circles
2012 ARDEA BIOSCIENCES, INC. : Securities Lawyers at Goldfarb LLP Seeking More Money,..
2012 Warner Chilcott to explore sale of company
2012 ARDEA BIOSCIENCES, INC. : Law Office of Brodsky & Smith, LLC Announces Investiga..
2012DJPharma M&A Surge Spurred By Necessity And Opportunity
2012 AstraZeneca CEO quits as drug sales tumble
2012 Watson to buy Actavis for at least $5.6 billion
More news
Sector news : Bio Therapeutic Drugs
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/21DJGILEAD SCIENCES : Halts Test of Bowel Disease Treatment
09/20 Bayer raises sales targets for top-selling drugs after Monsanto deal
More sector news : Bio Therapeutic Drugs
Advertisement
Income Statement Evolution
More Financials
Sector and Competitors
1st jan.Capitalization (M$)
ARDEA BIOSCIENCES, INC..0
AMGEN, INC.7.68%130 813
GILEAD SCIENCES, INC.-19.59%107 381
CELGENE CORPORATION-8.63%84 821
REGENERON PHARMACEUTIC..-24.40%43 212
VERTEX PHARMACEUTICALS..-27.97%22 456
More Results